Business Context and Reporting Period
Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 8-K (Current Report)
Date of Report: February 25, 2026
Reporting Period: This filing reports on specific events occurring on February 25, 2026, and references the Annual Report for the year ended December 31, 2025.
Key Financial Metrics
This Form 8-K does not provide comprehensive financial statements, revenue, profit, cash flow, or liquidity metrics for the reporting period. The filing focuses on a specific legal contingency.
- Legal Reserve: An $18 million legal reserve was recorded in the third quarter of 2025 related to the St. Mary's Medical Group lawsuit.
- Potential Exposure: A previous jury verdict included approximately $4.7 million in compensatory damages and $500 million in punitive damages against UHS of Delaware, Inc.
Material Changes and Legal Developments
The primary material event disclosed is a significant development in the lawsuit St. Mary's Medical Group, Inc. et. al. v. Pinnacle Medical Group, Northern Nevada, et. al.
- Previous Verdict: A trial concluded on September 26, 2025, resulting in a verdict against UHS of Delaware, Inc. for approximately $4.7 million in compensatory damages and $500 million in punitive damages.
- New Ruling: On February 25, 2026, the judge issued a verbal order granting a new trial based on juror misconduct.
- Impact: The entire verdict is anticipated to be vacated, and a new trial will be scheduled. Plaintiffs may appeal this ruling.
- Statutory Caps: Even if the verdict is reinstated on appeal, Nevada statutory law would likely reduce punitive damages to a maximum of approximately $14 million, with potential for further reduction under recent precedent.
Outlook, Risks, and Management Commentary
Management states that while the new trial order is favorable, the ultimate financial exposure remains uncertain. The company notes that if the matter is decided adversely, it could have a material adverse effect on the Company's financial condition. The $18 million reserve recorded in Q3 2025 remains in place pending the outcome of the new trial and any appeals.
Investor Verification Checklist
- Verify the status of the $18 million legal reserve recorded in Q3 2025 and whether it requires adjustment following the new trial order.
- Monitor for any appeal filings by the plaintiffs challenging the judge's order for a new trial.
- Review the full Annual Report (10-K) filed on February 25, 2026, for comprehensive financial performance data not included in this 8-K.
- Assess the potential timeline for the rescheduled trial and its impact on future legal expenses.